Search - tctmd.com

Displaying 1 - 20 of 47

Sort: Relevancy | Date

Imperfect Evidence: How Strong Is the Case for Transcatheter Tricuspid Valve Interventions?

News Features

Imperfect Evidence: How Strong Is the Case for Transcatheter Tricuspid Valve Interventions?

October 22, 2025

Weight-Loss Showdown: Is It Time for an RCT of Bariatric Surgery vs GLP-1s?

News Features

Weight-Loss Showdown: Is It Time for an RCT of Bariatric Surgery vs GLP-1s?

Michael O'Riordan

January 17, 2025

Reimbursement Issues Seem to Be Holding Renal Denervation Back

News Features

Reimbursement Issues Seem to Be Holding Renal Denervation Back

December 19, 2024

Initial US Commercial TriClip Cases Offer Hope, but Reimbursement Still a Big Question

News Features

Initial US Commercial TriClip Cases Offer Hope, but Reimbursement Still a Big Question

August 09, 2024

The Promise of Pulsed-Field Ablation: Cautious Optimism Amid Some Unknowns

News Features

The Promise of Pulsed-Field Ablation: Cautious Optimism Amid Some Unknowns

March 29, 2024

FDA Clears AI-ECG Screening Tools for CV Care: What’s Next Is Up for Grabs

News Features

FDA Clears AI-ECG Screening Tools for CV Care: What’s Next Is Up for Grabs

Yael L. Maxwell

December 14, 2023

Skyrocketing Popularity Puts GLP-1 Agonists for Weight Loss on Cardiology’s Radar

News Features

Skyrocketing Popularity Puts GLP-1 Agonists for Weight Loss on Cardiology’s Radar

May 12, 2023

Myriad Novel Devices Aim to Boost Decongestion in Acute HF

News Features

Myriad Novel Devices Aim to Boost Decongestion in Acute HF

April 10, 2023

ChatGPT et al? Not So Fast, Say Journal Editors

News Features

ChatGPT et al? Not So Fast, Say Journal Editors

Yael L. Maxwell

April 05, 2023

From Mountains to Meds: A Grassroots Effort Is Restocking Cath Labs in Ukraine

News Features

From Mountains to Meds: A Grassroots Effort Is Restocking Cath Labs in Ukraine

October 18, 2022

Novel Targets, Gene Edits, and Vaccines: Is a ‘Golden Era’ Dawning for ASCVD?

News Features

Novel Targets, Gene Edits, and Vaccines: Is a ‘Golden Era’ Dawning for ASCVD?

Michael O'Riordan

August 15, 2022

Pricey Inclisiran Is Rolling Out: a ‘Buy-and-Bill’ Model May Smooth Its Path

News Features

Pricey Inclisiran Is Rolling Out: a ‘Buy-and-Bill’ Model May Smooth Its Path

Michael O'Riordan

January 17, 2022

Expired Cardiac Devices May Do Global Good, but Safety Unknown

News Features

Expired Cardiac Devices May Do Global Good, but Safety Unknown

Yael L. Maxwell

August 26, 2021

Roughly 80% of ESC Guideline Writers Have Financial COIs

News Features

Roughly 80% of ESC Guideline Writers Have Financial COIs

Michael O'Riordan

April 01, 2021

Funding the Future: How Industry Support for CV Trials Could Evolve

News Features

Funding the Future: How Industry Support for CV Trials Could Evolve

Michael O'Riordan

December 17, 2020

Hospitals Plan Cautious Restart to Elective Procedures as COVID-19 Wanes

News Features

Hospitals Plan Cautious Restart to Elective Procedures as COVID-19 Wanes

Michael O'Riordan

May 12, 2020

Dire, Unusual STEMI Complications Blamed on COVID-19 Hospital Avoidance

News Features

Dire, Unusual STEMI Complications Blamed on COVID-19 Hospital Avoidance

April 29, 2020

News Features

The Mystery of the Missing STEMIs During the COVID-19 Pandemic

April 02, 2020

‘Outrageous’ $225,000 per Year List Price for Tafamidis Draws Outcry

News Features

‘Outrageous’ $225,000 per Year List Price for Tafamidis Draws Outcry

Michael O'Riordan

January 10, 2020

Year in Review: Physicians Pick the Biggest News of 2019

News Features

Year in Review: Physicians Pick the Biggest News of 2019

TCTMD News Team

December 30, 2019

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.